<DOC>
	<DOCNO>NCT00148915</DOCNO>
	<brief_summary>The purpose randomize , double-blind , placebo-controlled study estimate effect oral ibandronate sodium ( Boniva ) take monthly versus placebo bone quality strength proximal femur one year .</brief_summary>
	<brief_title>A Study To Assess Quality Strength Bone Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Ibandronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Inclusion criterion : Ambulatory , postmenopausal woman age 55 80 year diagnose osteoporosis BMD TScore less equal ( &lt; = ) 2.0 total spine total femur total neck , BMD Tscore great equal ( &gt; = ) 5.0 3 site Exclusion criterion : Have treat bisphosphonates use chronic steroid within past 6 month Have history major upper gastrointestinal ( GI ) diseases severe kidney dysfunction Have spine fracture ( identified Xray )</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>bisphosphonates</keyword>
	<keyword>bone</keyword>
</DOC>